Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-07-12 Sale |
2023-07-14 7:01 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
15,000 | $125.81 | $1,887,081 | 14,968,952 (Indirect Direct) |
View |
| 2023-07-11 Purchase |
2023-07-13 5:15 pm |
Evelo Biosciences Inc. | EVLO | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Nutritional Health LTP Fund General Partner LLC Nutritional Health LTP Fund L.P. Flagship Pioneering Inc. Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. AFEYAN NOUBAR 10% Owner |
5,411,255 | $2.31 | $12,499,999 | 4,977,588 (Indirect) |
View |
| 2023-07-05 Sale |
2023-07-07 7:00 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
15,000 | $124.73 | $1,870,933 | 14,983,952 (Indirect Direct) |
View |
| 2023-06-28 Sale |
2023-06-30 7:02 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
15,000 | $121.54 | $1,823,160 | 14,998,952 (Indirect Direct) |
View |
| 2023-06-21 Sale |
2023-06-23 7:01 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
15,000 | $121.95 | $1,829,227 | 15,013,952 (Indirect Direct) |
View |
| 2023-06-14 Sale |
2023-06-16 7:00 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
15,000 | $126.18 | $1,892,627 | 15,028,952 (Indirect Direct) |
View |
| 2023-06-07 Sale |
2023-06-09 7:00 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
15,000 | $125.91 | $1,888,601 | 15,043,952 (Indirect Direct) |
View |
| 2023-06-06 Sale |
2023-06-08 7:00 pm |
Sana Biotechnology Inc. | SANA | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner |
403,758 | $6.2732 | $2,532,858 | 22,546,725 (Indirect) |
View |
| 2023-05-31 Sale |
2023-06-02 7:00 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
15,000 | $127.35 | $1,910,322 | 15,058,952 (Indirect Direct) |
View |
| 2023-05-24 Sale |
2023-05-26 8:00 pm |
Sana Biotechnology Inc. | SANA | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner |
545,242 | $6.4692 | $3,527,275 | 22,591,782 (Indirect) |
View |
| 2023-03-01 Sale |
2023-03-03 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $139 | $1,390,000 | 15,073,952 (Indirect Direct) |
View |
| 2023-02-27 Purchase |
2023-02-27 5:20 pm |
Omega Therapeutics Inc. | OMGA | Flagship Pioneering Inc. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Special Opportunities Fund II L.P. AFEYAN NOUBAR 10% Owner |
3,323,310 | $5.78 | $19,208,732 | 21,716,886 (Indirect) |
View |
| 2023-02-22 Sale |
2023-02-24 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $160.35 | $1,603,500 | 15,083,952 (Indirect Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $173.17 | $1,731,700 | 15,093,952 (Indirect Direct) |
View |
| 2023-02-08 Sale |
2023-02-10 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
20,000 | $167.84 | $3,356,761 | 15,103,952 (Indirect Direct) |
View |
| 2023-01-25 Sale |
2023-01-27 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $194.33 | $1,943,300 | 15,123,952 (Indirect Direct) |
View |
| 2023-01-18 Sale |
2023-01-20 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $200.2 | $2,002,000 | 15,133,952 (Indirect Direct) |
View |
| 2023-01-11 Sale |
2023-01-13 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $188.57 | $1,885,700 | 15,143,952 (Indirect Direct) |
View |
| 2023-01-04 Sale |
2023-01-06 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $182.15 | $1,821,500 | 15,153,952 (Indirect Direct) |
View |
| 2022-12-21 Sale |
2022-12-23 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $201.7 | $2,017,000 | 15,163,952 (Indirect Direct) |
View |
| 2022-12-14 Sale |
2022-12-16 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $195 | $1,950,000 | 15,173,952 (Indirect Direct) |
View |
| 2022-12-07 Sale |
2022-12-09 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $172.16 | $1,721,600 | 15,183,952 (Indirect Direct) |
View |
| 2022-11-30 Sale |
2022-12-02 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $173.52 | $1,735,200 | 15,193,952 (Indirect Direct) |
View |
| 2022-11-23 Sale |
2022-11-25 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $178.01 | $1,780,100 | 15,203,952 (Indirect Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $184.25 | $1,842,500 | 15,213,952 (Indirect Direct) |
View |
| 2022-11-09 Sale |
2022-11-10 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $162.5 | $1,625,000 | 15,223,952 (Indirect Direct) |
View |
| 2022-11-02 Sale |
2022-11-04 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $154.2 | $1,542,000 | 15,233,952 (Indirect Direct) |
View |
| 2022-10-26 Sale |
2022-10-28 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $137.25 | $1,372,500 | 15,243,952 (Indirect Direct) |
View |
| 2022-10-19 Sale |
2022-10-21 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $132.5 | $1,325,000 | 15,253,952 (Indirect Direct) |
View |
| 2022-10-13 Purchase |
2022-10-17 4:42 pm |
Axcella Health Inc. | AXLA | Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures Opportunities Fund I General Partner LLC Flagship Ventures Opportunities Fund I L.P. AFEYAN NOUBAR 10% Owner |
10,383,760 | $1.64 | $17,029,366 | 8,850,296 (Indirect) |
View |
| 2022-10-12 Sale |
2022-10-14 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $135.36 | $1,353,600 | 15,263,952 (Indirect Direct) |
View |
| 2022-10-05 Sale |
2022-10-07 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $122.4 | $1,224,000 | 15,273,952 (Indirect Direct) |
View |
| 2022-09-28 Sale |
2022-09-30 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $123.58 | $1,235,800 | 15,283,952 (Indirect Direct) |
View |
| 2022-09-21 Sale |
2022-09-23 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $130.37 | $1,303,700 | 15,293,952 (Indirect Direct) |
View |
| 2022-09-15 Purchase |
2022-09-16 7:30 pm |
Codiak BioSciences Inc. | CDAK | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship V VentureLabs Rx Fund L.P. AFEYAN NOUBAR 10% Owner |
933,333 | $0 | $0 | 2,608,202 (Indirect) |
View |
| 2022-09-14 Sale |
2022-09-16 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $134 | $1,340,000 | 15,303,952 (Indirect Direct) |
View |
| 2022-09-07 Sale |
2022-09-09 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $129.68 | $1,296,800 | 15,313,952 (Indirect Direct) |
View |
| 2022-08-31 Sale |
2022-09-02 7:30 pm |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
10,000 | $136.95 | $1,369,500 | 15,323,952 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-07 Option Award |
2023-06-09 4:05 pm |
N/A 2033-06-06 |
Omega Therapeutics Inc. | OMGA | AFEYAN NOUBAR Director 10% Owner |
18,118 | $0 | 18,118 (Direct) |
View |
| 2023-05-03 Option Award |
2023-05-05 4:09 pm |
N/A 2033-05-03 |
Moderna Inc. | MRNA | AFEYAN NOUBAR Director |
6,134 | $0 | 6,134 (Direct) |
View |